FAQs

Certara accelerates medicines to patients by transforming traditional drug discovery and development with our end-to-end platform, powered by biosimulation software, technology, and great people.

4 Radnor Corporate Center
Suite 350
Radnor, PA 19087

Our main phone number is 415-CER-TARA (237-8272).

Certara is listed on the Nasdaq stock exchange under the ticker symbol “CERT.”

Certara’s initial public offering was on December 11, 2020 at $23 per share.

Certara’s fiscal year end is December 31.

Certara does not pay a dividend.

Certara does not offer a direct stock purchase plan at this time.

Information on Certara’s Leadership team and Board of Directors can be found here.

Our latest press releases can be found here, and financial reports can be found here.

SEC filings can be found here.

Our transfer agent is Broadridge and can be reached at:
 

Website:shareholder.broadridge.com
E-mail:shareholder@broadridge.com
Telephone:1-844-998-0339 (Toll-Free Number) or 1-303-562-9304 (Toll Number)

 

Mail: Regular MailOvernight Mail
 Broadridge Shareholder Services
c/o Broadridge Corporate Issuer Solutions
PO Box 1342
Brentwood, NY 11717-0718
Broadridge Shareholder Services
c/o Broadridge Corporate Issuer Solutions
1155 Long Island Avenue
Edgewood, NY 11717-8309
Attn: IWS


Registered stockholders, including those who hold physical stock certificates, should contact Broadridge in the event of a name change, a change of address or if their certificate has been lost or stolen.

Additionally, if a registered holder has not received notification of the availability of our proxy statement and annual report in advance of the Annual Meeting, Broadridge is the appropriate contact

Please fill out this contact form  to join our email list.

Please contact ir@certara.com.